Mast Cells and the Host Response in the Lung
Mast Cells and the Host Response in the Lung
批准号:
7244388
负责人:
Paul j WOLTERS
金额:
$35.91万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-02 至 2009-06-30
关键词:
AffectAntibioticsBacterial InfectionsBacterial PneumoniaBlood VesselsCathepsin CCause of DeathCell CountCellsCessation of lifeChymaseComplementDevelopmentEndopeptidasesEndothelial CellsEnzyme-Linked Immunosorbent AssayEpithelial CellsFibroblastsGene ExpressionGenesHigh Pressure Liquid ChromatographyHost DefenseHydrolysisImmune responseIn VitroIncubatedInfectionInflammation MediatorsInflammatoryInterleukin-10Interleukin-6Klebsiella pneumonia bacteriumKnockout MiceKnowledgeLeadLocationLungLymphocyteMeasuresMediatingMediator of activation proteinMesenchymalMethodsModelingMusNoseOutcomePatientsPeptide HydrolasesPeritonitisPhysiologicalPlayPneumoniaProductionProteinsProteolysisRecruitment ActivityReportingResearchResearch PersonnelRiskRoleSerumSiteSourceTechniquesTestingTissuesTryptaseTumor Necrosis Factor-alphaUnited StatesWorkairway epitheliumbasecytokinehuman TNF proteinimprovedin vivoinsightmacrophagemast cellmouse modelneutrophilprogramsreconstitutionresearch studyresponsesensorseptic
中文摘要
描述(由申请人提供):我们研究的长期目标是确定肥大细胞调节宿主对细菌性肺部感染反应的机制,并能够改变肥大细胞如何以有益于宿主的方式协调这种反应。最近,我们发现肥大细胞蛋白酶二肽基肽酶I(DPPI)有助于宿主死于脓毒性腹膜炎,并且似乎通过调节肥大细胞IL-6的水平来实现。这表明肥大细胞DPPI或由DPPI调节的其他肥大细胞蛋白以损害宿主的方式改变宿主对细菌感染的反应。我们的中心假设是:肥大细胞蛋白酶和细胞因子协调肺防御细菌感染。在协调这种防御的同时,这些介质中的一些保护宿主并改善生存,而另一些则伤害宿主并恶化生存。具体目标是:#1。确定肥大细胞DPPI调节细菌性肺部感染的宿主反应和存活的机制。这将通过应用一种新的方法来建立肥大细胞特异性敲除小鼠,并确定接种肺炎克雷伯氏菌后存活的生理机制来实现。#2.明确细菌感染时肥大细胞蛋白酶调节细胞因子水平的机制。我们将通过将细胞因子与纯化的DPPI、类胰蛋白酶或糜蛋白酶孵育并鉴定裂解产物来测试肥大细胞蛋白酶是否水解细胞因子。蛋白酶介导的细胞因子产生将通过测量特定肺细胞响应DPPI、类胰蛋白酶或糜蛋白酶释放的细胞因子来研究。#3.确定肥大细胞TNF-α、IL-6或IL-10是否调节细菌性肺部感染的宿主应答和存活。我们将使用肥大细胞特异性-TNF-α,-IL-6,或-IL-10敲除小鼠来测试这些细胞因子的肥大细胞来源是否在宿主防御中起重要作用。通过了解特定的肥大细胞介质如何调节宿主防御,我们将更深入地了解这些细胞如何影响宿主的生存。这些知识可以应用于细菌性肺炎的新治疗方法的开发,这些方法可以以提高生存率的方式调节特定肥大细胞蛋白的活性。
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of our research is to determine the mechanisms by which mast cells regulate the host response to bacterial lung infections and to be able to modify how mast cells coordinate this response in ways that benefit the host. Recently, we made the discovery that the mast cell protease dipeptidyl peptidase I (DPPI) contributes to death of the host from septic peritonitis and that it appears to do so by regulating levels of mast cell IL-6. This suggests that mast cell DPPI, or other mast cell proteins regulated by DPPI, modify the host response to bacterial infection in ways that harm the host. Our central hypothesis is that: Mast cell proteases and cytokines coordinate lung defense against bacterial infections. While coordinating this defense, some of these mediators protect the host and improve survival while others harm the host and worsen survival. Specific aims are: #1. To determine the mechanism by which mast cell DPPI modulates the host response and survival from bacterial lung infections. This will be accomplished by applying a new method for creating mast cell-specific knockout mice and determining the physiologic mechanism for survival following inoculation with Klebsiella pneumoniae. #2. To define mechanisms by which mast cell proteases regulate cytokine levels during bacterial infections. We will test whether mast cell proteases hydrolyze cytokines by incubating cytokines with purified DPPI, tryptase or chymase and identifying cleavage products. Protease mediated cytokine production will be studied by measuring cytokines released by specific lung cells in response to DPPI, tryptase or chymase. #3. To determine whether mast cell TNF-alpha, IL-6, or IL-10 modulate the host response and survival from bacterial lung infections. We will use mast cell-specific-TNF-alpha, -IL-6, or -IL-10 knockout mice to test if mast cell sources of these cytokines play important roles in host defense. By understanding how specific mast cell mediators regulate host defense, we will gain greater insight into how these cells influence host survival. This knowledge can then be applied to the development of new treatments for bacterial pneumonia that modulate the activity of specific mast cells proteins in ways that improve survival.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4049/jimmunol.181.8.5598
发表时间:
2008-10-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Sutherland RE, Olsen JS, McKinstry A, Villalta SA, Wolters PJ]
通讯作者:
Wolters PJ
Lung Remodeling Mediated by Telomere Dysfunction in Alveolar Type II Cells
-
批准号:10660570
-
项目类别:
-
资助金额:$79.93万
-
财政年份:2018
-
负责人:Paul j WOLTERS
-
依托单位:
Lung fibrosis mediated by telomere dysfunction in alveolar type II cells
-
批准号:10200132
-
项目类别:
-
资助金额:$59.27万
-
财政年份:2018
-
负责人:Paul j WOLTERS
-
依托单位:
Analysis of Alveolar Type II cells in Normal and Fibrotic Human Lung
-
批准号:8113080
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2011
-
负责人:Paul j WOLTERS
-
依托单位:
Analysis of Alveolar Type II cells in Normal and Fibrotic Human Lung
-
批准号:8249365
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2011
-
负责人:Paul j WOLTERS
-
依托单位:
Mast Cells and the Host Response in the Lung
-
批准号:6917109
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2004
-
负责人:Paul j WOLTERS
-
依托单位:
Mast Cells and the Host Response in the Lung
-
批准号:6820426
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2004
-
负责人:Paul j WOLTERS
-
依托单位:
Mast Cells and the Host Response in the Lung
-
批准号:7088884
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2004
-
负责人:Paul j WOLTERS
-
依托单位:
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION
-
批准号:6388547
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1999
-
负责人:Paul j WOLTERS
-
依托单位:
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION
-
批准号:2881397
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1999
-
负责人:Paul j WOLTERS
-
依托单位:
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION
-
批准号:6183187
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1999
-
负责人:Paul j WOLTERS
-
依托单位:
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION
-
批准号:6526737
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1999
-
负责人:Paul j WOLTERS
-
依托单位:
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION
-
批准号:6616767
-
项目类别:
-
资助金额:$12.18万
-
财政年份:1999
-
负责人:Paul j WOLTERS
-
依托单位:
Human Cells and Tissues/Sheppard
-
批准号:8703759
-
项目类别:
-
资助金额:$34.54万
-
财政年份:--
-
负责人:Paul j WOLTERS
-
依托单位:
Human Cells and Tissues/Sheppard
-
批准号:8527839
-
项目类别:
-
资助金额:$33.41万
-
财政年份:--
-
负责人:Paul j WOLTERS
-
依托单位:
Human Cells and Tissues/Sheppard
-
批准号:8401280
-
项目类别:
-
资助金额:$35.95万
-
财政年份:--
-
负责人:Paul j WOLTERS
-
依托单位:
海外基金